Purchase Order 75N92025P00022

Award Date 11/25/24
Potential Completion Date 11/24/25
Potential Value $50K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,861.82 firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for Illumina's iSelect 8x1 LCG Custom DNA Analysis Kits to support genotyping of human genomes from transplantation patients. This award is not associated with any set-aside designation. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents, and has provided...
This firm fixed-price delivery order was awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $110,254.47, is with Illumina, Inc., a manufacturer of genomic sequencing systems and consumables. Illumina has provided these products and associated services to support genomic research and analysis across various federal agencies in the past. This order does not include any set-aside...
This is a $303,238.66 firm fixed price delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc. The contract is for the provision of various Illumina sequencing systems, reagents, and consumables to support genomic sequencing and analysis for research and diagnostic purposes. Illumina is the sole manufacturer of the specified sequencing platforms. This award is part of a larger Indefinite...
This is a firm fixed price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract has a ceiling value of $646,396.36 and no set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, will provide a range of sequencing systems, reagents, and services to support NHLBI's research and diagnostics needs. Illumina has a history of...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) National Human Genome Research Institute to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $147,003.32 award provides Illumina goods and services including sequencing systems, reagents, and related support for genomic research and diagnostics purposes. Illumina has a history of prime federal contract awards across agencies like NIH, CDC, USDA, and VA, supplying...
This is a firm fixed-price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian federal agency. The $42,511.56 contract is for Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, to provide Illumina sequencing kits and reagents to support next-generation DNA sequencing activities at the NHLBI Sequencing Core Facility. The contract has a performance period ending on...
This is a firm fixed-price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The $383,592.54 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis. The award is not set aside and was made on a sole-source basis, with Illumina identified as the sole manufacturer of the required sequencing...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $15,575 contract is for the delivery of Illumina's proprietary sequencing systems, reagents, and related products and services to support the Institute's genomic research and diagnostics activities. This award is not associated with any...
This is a firm fixed-price delivery order issued by the National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc. for Illumina sequencing kits and reagents. The $40,775.91 order is to support next-generation sequencing on Illumina instruments for NHLBI researchers and investigators. Illumina is the sole manufacturer of these proprietary sequencing systems. This delivery order is part of a larger Indefinite Delivery Contract the...
This $111,697.92 firm fixed-price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. for DNA analysis kits. The contract is not associated with a set-aside or larger contract vehicle. Illumina is a manufacturer of sequencing and array-based genomic analysis solutions, and has provided a range of sequencing instruments, reagents, and services to support research and...

This is a firm fixed price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $49,723.63, is for Illumina, Inc. to provide an iSelect 8x1 LCG Custom DNA Analysis Kit. The award does not have a set-aside designation. Illumina is the prime contractor and manufacturer of the sequencing systems and consumables being procured. Past Illumina federal contract awards have supported genomic sequencing and analysis for research and diagnostic purposes across various government agencies. The award is not associated with a larger contract vehicle, but Illumina does hold an Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to provide sequencing reagents and controls for their biological threat characterization efforts.

Generated 12/3/24, 10:07 AM